Voyager Therapeutics (VYGR) PT Lowered to $18 at Wedbush
- Dow, S&P futures inch higher as banks, energy stocks jump
- EV Company Polestar To Go Public Via $20 Billion SPAC Deal
- Amazon (AMZN) Price Target Lowered at Morgan Stanley Amid Rising Logistics Workforce Costs, Analyst Expects Stock to be Range Bound in Near Term
- Acceleron Pharma (XLRN) Said in Advanced Talks for $11 Billion Sale - Bloomberg (Earlier)
- Brent oil nears $80 a barrel amid supply constraints
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Wedbush analyst David Nierengarten lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $18.00 (from $28.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JPMorgan Upgrades ICON plc (ICLR) to Overweight
- Oshkosh (OSK) PT Lowered to $125 at KeyBanc
- Subaru Corp. (7270:JP) (FUJHY) PT Lowered to JPY2,200 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!